United States Healthcare Equipment & Supplies

TELA Bio Inc (TELA)

Track

Track

TELA Bio Inc. recorded seven insider trading transactions over the past ninety days, all representing purchases totaling $216,545.75. These acquisitions occurred following the August 2026 results financiers, where the firm missed earnings expectations. Despite this performance, the stock price appreciated 59% during the period, reflecting significant buying activity from two distinct insiders.
Ticker: TELA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for TELA Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Capper Joseph H Non-Executive Director
Transaction date
Purchase
Price
308.01
Quantity 575 -27.0%
Value US$2,329,907
3.4
Capper Joseph H Non-Executive Director
Transaction date
Purchase
Price
270.87
Quantity 58,135 -36.8%
Value US$3,881,375
3.4
Capper Joseph H Non-Executive Director
Transaction date
Purchase
Price
387.16
Quantity 80,738 -23.2%
Value US$1,950,750
3.4
Capper Joseph H Non-Executive Director
Transaction date
Purchase
Price
1.06
Quantity 1,000 +91.2%
Value US$100,000
3.4
Capper Joseph H Non-Executive Director
Transaction date
Purchase
Price
1.02
Quantity 1,000 +83.8%
Value US$100,000
3.6
Getz Heather C Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.66
Quantity 12,500 +2.4%
Value US$8,311
3.6
Getz Heather C Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.70
Quantity 15,000 +3.0%
Value US$10,467
3.3
Cuca Roberto COO and CFO Officer
Transaction date
Planned purchase
Price
2.25
Quantity 64,444 +70.9%
Value US$144,999
Talmo Paul Chief Technology Officer Officer
Transaction date
Purchase
Price
2.25
Quantity 22,222 +32.3%
Value US$50,000
2.5
Firestone Gregory A. Chief Commercial Officer Officer
Transaction date
Purchase
Price
2.25
Quantity 6,666 +13.2%
Value US$14,998
3.2
KOBLISH ANTONY Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.25
Quantity 88,888 +24.0%
Value US$199,998
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.54
Quantity 36,600 -1.5%
Value US$166,164
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.68
Quantity 13,700 -0.6%
Value US$64,116
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
4.74
Quantity 378,000 -13.3%
Value US$1,791,720
2.5
Firestone Gregory A. Chief Business Officer Officer
Transaction date
Purchase
Price
5.65
Quantity 2,600 +7.9%
Value US$14,688
3.2
KOBLISH ANTONY Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.54
Quantity 11,000 +3.8%
Value US$49,976
3.3
Cuca Roberto COO and CFO Officer
Transaction date
Planned purchase
Price
4.49
Quantity 10,000 +19.1%
Value US$44,938
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
9.41
Quantity 27,700 -1.0%
Value US$260,657
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
9.43
Quantity 28,300 -1.0%
Value US$266,869
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
9.30
Quantity 136,000 -4.5%
Value US$1,264,800
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
7.81
Quantity 19,000 +1.0%
Value US$148,426
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 1,000 +0.8%
Value US$8,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 15,000 +0.8%
Value US$120,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
7.99
Quantity 6,500 +0.3%
Value US$51,962
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.09
Quantity 1,000 +0.8%
Value US$8,088
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.09
Quantity 17,000 +0.9%
Value US$137,496
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.08
Quantity 2,000 +0.1%
Value US$16,166
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.10
Quantity 3,500 +0.2%
Value US$28,350
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.10
Quantity 5,000 +0.3%
Value US$40,496
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 15,000 +14.3%
Value US$120,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 300,000 +19.0%
Value US$2,400,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.52
Quantity 11,500 +0.7%
Value US$98,006
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.02
Quantity 5,000 +0.3%
Value US$40,105
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.03
Quantity 9,500 +0.6%
Value US$76,282
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
8.08
Quantity 4,500 +0.3%
Value US$36,346
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.99
Quantity 2,000 +0.1%
Value US$13,980
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.50
Quantity 50,000 +3.4%
Value US$324,975
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-17 B Purchase
3.4
Capper Joseph H
Non-Executive Director
575 -27.0%
308.01
US$2,329,907 		575 -27.0% 308.01 US$2,329,907
2026-09-18 2026-09-17 B Purchase
3.4
Capper Joseph H
Non-Executive Director
58,135 -36.8%
270.87
US$3,881,375 		58,135 -36.8% 270.87 US$3,881,375
2026-09-18 2026-09-16 B Purchase
3.4
Capper Joseph H
Non-Executive Director
80,738 -23.2%
387.16
US$1,950,750 		80,738 -23.2% 387.16 US$1,950,750
2026-09-16 2026-09-15 B Purchase
3.4
Capper Joseph H
Non-Executive Director
1,000 +91.2%
1.06
US$100,000 		1,000 +91.2% 1.06 US$100,000
2026-09-16 2026-09-14 B Purchase
3.4
Capper Joseph H
Non-Executive Director
1,000 +83.8%
1.02
US$100,000 		1,000 +83.8% 1.02 US$100,000
2026-08-19 2026-08-17 B Purchase
3.6
Getz Heather C

Chief Executive Officer

Executive Director
12,500 +2.4%
0.66
US$8,311 		12,500 +2.4% 0.66 US$8,311
2026-08-17 2026-08-14 B Purchase
3.6
Getz Heather C

Chief Executive Officer

Executive Director
15,000 +3.0%
0.70
US$10,467 		15,000 +3.0% 0.70 US$10,467
2025-11-17 2025-11-17 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See Remarks

Large shareholder
3,604,000 +87.7%
1.11
US$4,000,440 		3,604,000 +87.7% 1.11 US$4,000,440
2024-10-24 2024-10-24 PP Planned purchase
3.3
Cuca Roberto

COO and CFO

Officer
64,444 +70.9%
2.25
US$144,999 		64,444 +70.9% 2.25 US$144,999
2024-10-24 2024-10-24 B Purchase
Talmo Paul

Chief Technology Officer

Officer
22,222 +32.3%
2.25
US$50,000 		22,222 +32.3% 2.25 US$50,000
2024-10-24 2024-10-24 B Purchase
2.5
Firestone Gregory A.

Chief Commercial Officer

Officer
6,666 +13.2%
2.25
US$14,998 		6,666 +13.2% 2.25 US$14,998
2024-10-24 2024-10-24 B Purchase
3.2
KOBLISH ANTONY

Chief Executive Officer

Executive Director
88,888 +24.0%
2.25
US$199,998 		88,888 +24.0% 2.25 US$199,998
2024-07-02 2024-07-02 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
36,600 -1.5%
4.54
US$166,164 		36,600 -1.5% 4.54 US$166,164
2024-07-02 2024-07-01 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
13,700 -0.6%
4.68
US$64,116 		13,700 -0.6% 4.68 US$64,116
2024-07-02 2024-06-28 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
378,000 -13.3%
4.74
US$1,791,720 		378,000 -13.3% 4.74 US$1,791,720
2024-06-28 2024-06-28 PrS Proposed sale
2.6
OrbiMed Private Investments IV, LP

Shareholder
428,386
5.14
US$2,201,904 		428,386 5.14 US$2,201,904
2023-12-07 2023-12-05 B Purchase
2.5
Firestone Gregory A.

Chief Business Officer

Officer
2,600 +7.9%
5.65
US$14,688 		2,600 +7.9% 5.65 US$14,688
2023-11-14 2023-11-14 B Purchase
3.2
KOBLISH ANTONY

Chief Executive Officer

Executive Director
11,000 +3.8%
4.54
US$49,976 		11,000 +3.8% 4.54 US$49,976
2023-11-14 2023-11-14 PP Planned purchase
3.3
Cuca Roberto

COO and CFO

Officer
10,000 +19.1%
4.49
US$44,938 		10,000 +19.1% 4.49 US$44,938
2023-04-21 2023-04-21 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
27,700 -1.0%
9.41
US$260,657 		27,700 -1.0% 9.41 US$260,657
2023-04-21 2023-04-20 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
28,300 -1.0%
9.43
US$266,869 		28,300 -1.0% 9.43 US$266,869
2023-04-21 2023-04-19 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
136,000 -4.5%
9.30
US$1,264,800 		136,000 -4.5% 9.30 US$1,264,800
2023-04-19 2023-04-19 PrS Proposed sale
2.6
OrbiMed Private Investments IV, LP

Shareholder
192,000
10.63
US$2,040,960 		192,000 10.63 US$2,040,960
2022-11-04 2022-11-03 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,262 +1.0%
7.81
US$9,859 		1,262 +1.0% 7.81 US$9,859
2022-11-04 2022-11-03 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
19,000 +1.0%
7.81
US$148,426 		19,000 +1.0% 7.81 US$148,426
2022-10-11 2022-10-11 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,000 +0.8%
8.00
US$8,000 		1,000 +0.8% 8.00 US$8,000
2022-10-11 2022-10-11 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
15,000 +0.8%
8.00
US$120,000 		15,000 +0.8% 8.00 US$120,000
2022-09-26 2022-09-23 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
304 +0.2%
7.99
US$2,430 		304 +0.2% 7.99 US$2,430
2022-09-26 2022-09-23 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
6,500 +0.3%
7.99
US$51,962 		6,500 +0.3% 7.99 US$51,962
2022-09-19 2022-09-19 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,000 +0.8%
8.09
US$8,088 		1,000 +0.8% 8.09 US$8,088
2022-09-19 2022-09-19 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
17,000 +0.9%
8.09
US$137,496 		17,000 +0.9% 8.09 US$137,496
2022-09-16 2022-09-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
372 +0.3%
8.08
US$3,007 		372 +0.3% 8.08 US$3,007
2022-09-16 2022-09-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
2,000 +0.1%
8.08
US$16,166 		2,000 +0.1% 8.08 US$16,166
2022-09-16 2022-09-15 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
658 +0.5%
8.10
US$5,330 		658 +0.5% 8.10 US$5,330
2022-09-16 2022-09-15 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
3,500 +0.2%
8.10
US$28,350 		3,500 +0.2% 8.10 US$28,350
2022-08-19 2022-08-17 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
500,000 +13.9%
8.00
US$4,000,000 		500,000 +13.9% 8.00 US$4,000,000
2022-09-15 2022-08-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
221 +0.2%
8.10
US$1,790 		221 +0.2% 8.10 US$1,790
2022-09-15 2022-08-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
5,000 +0.3%
8.10
US$40,496 		5,000 +0.3% 8.10 US$40,496
2022-08-16 2022-08-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
15,000 +14.3%
8.00
US$120,000 		15,000 +14.3% 8.00 US$120,000
2022-08-16 2022-08-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
300,000 +19.0%
8.00
US$2,400,000 		300,000 +19.0% 8.00 US$2,400,000
2022-08-12 2022-08-10 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
479 +0.5%
8.52
US$4,082 		479 +0.5% 8.52 US$4,082
2022-08-12 2022-08-10 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
11,500 +0.7%
8.52
US$98,006 		11,500 +0.7% 8.52 US$98,006
2022-08-02 2022-08-01 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
479 +0.5%
7.96
US$3,813 		479 +0.5% 7.96 US$3,813
2022-08-02 2022-08-01 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
4,500 +0.3%
7.96
US$35,819 		4,500 +0.3% 7.96 US$35,819
2022-07-22 2022-07-22 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
200 +0.2%
8.02
US$1,604 		200 +0.2% 8.02 US$1,604
2022-07-22 2022-07-22 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
5,000 +0.3%
8.02
US$40,105 		5,000 +0.3% 8.02 US$40,105
2022-07-21 2022-07-21 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
833 +0.8%
8.08
US$6,728 		833 +0.8% 8.08 US$6,728
2022-07-21 2022-07-21 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
9,500 +0.6%
8.03
US$76,282 		9,500 +0.6% 8.03 US$76,282
2022-07-20 2022-07-20 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
600 +0.6%
8.08
US$4,846 		600 +0.6% 8.08 US$4,846
2022-07-20 2022-07-20 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
4,500 +0.3%
8.08
US$36,346 		4,500 +0.3% 8.08 US$36,346
2024-02-16 2022-07-14 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See Remarks

Large shareholder
5,000 +0.1%
8.01
US$40,050 		5,000 +0.1% 8.01 US$40,050
2022-07-13 2022-07-13 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
8.03
US$40,150 		5,000 +0.1% 8.03 US$40,150
2022-07-13 2022-07-12 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
8.02
US$40,100 		5,000 +0.1% 8.02 US$40,100
2022-07-13 2022-07-11 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
8.02
US$40,100 		5,000 +0.1% 8.02 US$40,100
2022-07-08 2022-07-08 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.96
US$39,800 		5,000 +0.1% 7.96 US$39,800
2022-07-08 2022-07-07 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
8.07
US$40,350 		5,000 +0.1% 8.07 US$40,350
2022-07-08 2022-07-06 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.86
US$39,300 		5,000 +0.1% 7.86 US$39,300
2022-07-05 2022-07-05 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.52
US$37,600 		5,000 +0.1% 7.52 US$37,600
2022-07-05 2022-07-01 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
200 +0.2%
7.00
US$1,400 		200 +0.2% 7.00 US$1,400
2022-07-05 2022-07-01 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.27
US$36,350 		5,000 +0.1% 7.27 US$36,350
2022-07-05 2022-06-30 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.07
US$35,350 		5,000 +0.1% 7.07 US$35,350
2022-06-29 2022-06-28 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.10
US$35,500 		5,000 +0.1% 7.10 US$35,500
2022-06-29 2022-06-28 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.09
US$35,450 		5,000 +0.1% 7.09 US$35,450
2022-06-29 2022-06-27 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.22
US$36,100 		5,000 +0.1% 7.22 US$36,100
2022-06-24 2022-06-24 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
7.06
US$35,300 		5,000 +0.1% 7.06 US$35,300
2022-06-24 2022-06-23 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
6.99
US$34,950 		5,000 +0.1% 6.99 US$34,950
2022-06-24 2022-06-22 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
400 +0.4%
6.99
US$2,796 		400 +0.4% 6.99 US$2,796
2022-06-24 2022-06-22 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
2,000 +0.1%
6.99
US$13,980 		2,000 +0.1% 6.99 US$13,980
2022-06-24 2022-06-22 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
6.47
US$32,350 		5,000 +0.1% 6.47 US$32,350
2022-06-22 2022-06-22 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
50,000 +3.4%
6.50
US$324,975 		50,000 +3.4% 6.50 US$324,975
2022-06-21 2022-06-21 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
6.25
US$31,250 		5,000 +0.1% 6.25 US$31,250
2022-06-21 2022-06-17 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
6.17
US$30,850 		5,000 +0.1% 6.17 US$30,850
2022-06-21 2022-06-16 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
6.01
US$30,050 		5,000 +0.1% 6.01 US$30,050
2022-06-15 2022-06-15 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
5.90
US$29,500 		5,000 +0.1% 5.90 US$29,500
2022-06-15 2022-06-14 B Purchase
3.0
EW HEALTHCARE PARTNERS FUND 2, L.P.

See footnote 2
5,000 +0.1%
5.86
US$29,300 		5,000 +0.1% 5.86 US$29,300
Explore more

More insider trading research around TELA Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America